Infants who receive their first solid food either early or late — before the age of 4 months or at 6 months or older — are at increased risk of developing type 1 diabetes, new research suggests.
Dual achievement of both glycated hemoglobin and low-density lipoprotein cholesterol goals among patients with diabetes is associated with greater clinical and economic benefit than achievement of either goal alone, according to a study published online June 25 in Diabetes Care.
Will people with type 1 diabetes ever see an end to their need for insulin? For adults, that prospect doesn’t seem too likely. But new research from Boston Children’s Hospital generates genuine hope that by the time they are grownups, the 215,000 diabetic children in the US will be able put away their insulin kits […]
Insulin sensitizers–drugs that increase sensitivity to insulin such as Avandia and Actos–could help lessen the risk of peripheral arterial disease (PAD) for those with type 2 diabetes, according to a new study.
According to new research presented at the recent 73rd Scientific Sessions of the American Diabetes Association, this nutrient may also help lift mood and lower blood pressure in women who have Type 2 diabetes and depression.
Why do so many mothers have difficulty making enough milk to breastfeed? A new study by scientists at Cincinnati Children’s Hospital Medical Center and the University of California Davis adds to their previous research implicating insulin’s role in lactation success.
Good nut news! A new study showed that eating peanuts or peanut butter with breakfast limited the rise in blood glucose after both breakfast and lunch. This “second-meal” effect was completely unexpected and exciting.
Last week, 17,000 diabetes doctors and other professionals gathered at the American Diabetes Association’s 73rd Scientific Sessions. This is where the greatest minds in diabetes come to share research and debate the best path forward. Today, we are sharing highlights from the conference.
For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.
People have differing abilities to release and react to insulin depending on ethnicity, according to a new study from researchers at Lund University in Sweden, Stanford University and Kitasato University.
Infections that occur later don’t seem to pose as high as risk. When infants between 6 and 12 months had a respiratory illness, their risk only increased by 32 percent, the study found.
A “reverse vaccine” that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said.
Today, we bring you more from the American Diabetes Association’s 73rd Scientific Sessions in Chicago, an update on the most interesting new drugs, and some stand-out research.
Almost two decades after the landmark Diabetes Control and Complications Trial (DCCT) ended, we are still seeing dramatic reductions in diabetes complications achieved with intensive glycemic control in the intensive control group.
A study carried out in India examining the safety and efficacy of self-donated (autologous), transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M), has found that patients receiving the transplants, when compared to a control group of TD2M patients who did not receive transplantation, required less insulin post-transplantation.
It may be possible to reverse type 1 diabetes by training a patient’s own immune system to stop attacking their body, an early trial suggests. A study in 80 patients, published in the journal Science Translational Medicine, showed a vaccine could retrain their immune system.
In a breakthrough clinical trial, Stanford University researchers have created a never-before-seen vaccine that utilizes modified DNA to shut down specific sections of the immune system. The vaccine has shown promising results in combatting Type 1 diabetes, potentially paving the way for brand new treatments to help individuals with the disorder.
Type 2 diabetes tends to run in families: If parents have it, children are likely to get it too. But is that because of having similar genes, or similar behaviors? Maybe it’s neither. Maybe it’s having the same kind of bacteria in their guts.
Serum osteoprotegerin is an independent predictor of cardiovascular complications in adults with type 1 diabetes, according to a new analysis from the ongoing Finnish Diabetic Nephropathy (FinnDiane) Study.
Moderate-intensity exercise reduces fat stored around the heart, in the liver and in the abdomen of people with type 2 diabetes mellitus, even in the absence of any changes in diet, according to a new study published online in the journal Radiology.